Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
Titel:
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
Auteur:
Seront, E. Rottey, S. Sautois, B. Kerger, J. D'Hondt, L.A. Verschaeve, V. Canon, J.-L. Dopchie, C. Vandenbulcke, J.M. Whenham, N. Goeminne, J.C. Clausse, M. Verhoeven, D. Glorieux, P. Branders, S. Dupont, P. Schoonjans, J. Feron, O. Machiels, J.-P.